How has been the historical performance of Dr Agarwal's Eye?

Answer:The historical performance of Dr Agarwal's Eye shows a significant upward trend in net sales and profitability over the years.

Breakdown:
Dr Agarwal's Eye has demonstrated robust growth in net sales, increasing from 201.21 Cr in March 2022 to 397.15 Cr in March 2025. This growth is reflected in total operating income, which rose from 201.21 Cr in March 2022 to 397.15 Cr in March 2025. The company's operating profit, excluding other income, also improved significantly, reaching 118.50 Cr in March 2025, up from 57.68 Cr in March 2022. Profit before tax followed a similar trajectory, climbing from 32.31 Cr in March 2022 to 70.70 Cr in March 2025. Consequently, profit after tax increased from 24.10 Cr in March 2022 to 54.65 Cr in March 2025, showcasing a strong recovery from a loss of 1.44 Cr in March 2021. The earnings per share (EPS) also reflected this positive trend, rising from -3.06 in March 2021 to 116.28 in March 2025. On the balance sheet, total liabilities increased from 145.69 Cr in March 2021 to 485.73 Cr in March 2024, while total assets grew from 145.69 Cr to 485.73 Cr in the same period, indicating a solid expansion of the company's financial base. Cash flow from operating activities improved from 33 Cr in March 2021 to 89 Cr in March 2024, contributing to a net cash inflow of 5 Cr in March 2024. Overall, Dr Agarwal's Eye has shown a strong upward trajectory in both revenue and profitability, alongside a healthy cash flow position.